These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 7323274)
1. [Plutonium-329 metabolic characteristics during the separate and combined administration of an iron preparation and DTPA]. Shvydko NS; Rushonik SI; Popov DK; Likhtarev IA Radiobiologiia; 1981; 21(6):868-72. PubMed ID: 7323274 [No Abstract] [Full Text] [Related]
2. [Plutonium-239 distribution in the body in relation to the rhythm of administration of an iron preparation]. Rushonik SI; Shvydko NS Radiobiologiia; 1985; 25(3):410-4. PubMed ID: 4023194 [TBL] [Abstract][Full Text] [Related]
3. A mathematical model for estimation of plutonium in the human body from urine data influenced by DTPA therapy. Hall RM; Poda GA; Fleming RR; Smith JA Health Phys; 1978 May; 34(5):419-31. PubMed ID: 711453 [No Abstract] [Full Text] [Related]
4. Delivery of DTPA through Liposomes as a Good Strategy for Enhancing Plutonium Decorporation Regardless of Treatment Regimen. Grémy O; Miccoli L; Lelan F; Bohand S; Cherel M; Mougin-Degraef M Radiat Res; 2018 May; 189(5):477-489. PubMed ID: 29528770 [TBL] [Abstract][Full Text] [Related]
5. The use of Ca-DTPA as a treatment for plutonium inhaled in mixed oxide aerosols of plutonium and sodium. Stather JW; Rodwell P Health Phys; 1980 Nov; 39(5):801-5. PubMed ID: 7204032 [No Abstract] [Full Text] [Related]
6. Decorporation approach following rat lung contamination with a moderately soluble compound of plutonium using local and systemic Ca-DTPA combined chelation. Grémy O; Tsapis N; Bruel S; Renault D; Van der Meeren A Radiat Res; 2012 Sep; 178(3):217-23. PubMed ID: 22799632 [TBL] [Abstract][Full Text] [Related]
7. [Modification of the metabolism of intramuscularly injected plutonium-239 by means of an iron preparation]. Shvydko NS; Rushonik SI; Popov DK Radiobiologiia; 1983; 23(1):115-8. PubMed ID: 6828655 [No Abstract] [Full Text] [Related]
8. The influence of DTPA on the metabolism of inhaled 239PuF4 in beagles. McDonald KE; Dilley JV; Sanders CL; Mahaffey JA Health Phys; 1979 May; 36(5):632-5. PubMed ID: 489316 [No Abstract] [Full Text] [Related]
9. Decorporation of inhaled plutonium nitrate from hamsters using Zn-DTPA. Stradling GN; Stather JW; Sumner SA; Strong JC; Lennox AM; Ham SE Health Phys; 1984 Apr; 46(4):919-24. PubMed ID: 6706599 [No Abstract] [Full Text] [Related]
10. Structure of a single model to describe plutonium and americium decorporation by DTPA treatments. Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Fattal E; Benech H; Deverre JR; Poncy JL Health Phys; 2010 Oct; 99(4):553-9. PubMed ID: 20838098 [TBL] [Abstract][Full Text] [Related]
11. Experimental studies of the use of DTPA and other agents to limit the systemic burden of plutonium after wound contamination. Harrison JD; David AJ Radiat Res; 1979 Mar; 77(3):534-46. PubMed ID: 441257 [No Abstract] [Full Text] [Related]
12. Action of DTPA on hepatic plutonium. II. DTPA-induced removal of monomeric plutonium from mouse liver parenchymal cells. Bhattacharyya MH; Peterson DP; Lindenbaum A Radiat Res; 1978 Oct; 76(1):180-6. PubMed ID: 734044 [No Abstract] [Full Text] [Related]
13. Decorporation of plutonium by pulmonary administration of Ca-DTPA dry powder: a study in rat after lung contamination with different plutonium forms. Sérandour AL; Tsapis N; Gervelas C; Grillon G; Fréchou M; Deverre JR; Bénech H; Fattal E; Fritsch P; Poncy JL Radiat Prot Dosimetry; 2007; 127(1-4):472-6. PubMed ID: 17562654 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of orally administered amphipathic polyaminocarboxylic acid chelators for the removal of plutonium and americium: comparison with injected Zn-DTPA in the rat. Miller SC; Liu G; Bruenger FW; Lloyd RD Radiat Prot Dosimetry; 2006; 118(4):412-20. PubMed ID: 16332916 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of DTPA entrapped in conventional and long-circulating liposomes of different size for plutonium decorporation. Phan G; Herbet A; Cholet S; Benech H; Deverre JR; Fattal E J Control Release; 2005 Dec; 110(1):177-88. PubMed ID: 16257469 [TBL] [Abstract][Full Text] [Related]
16. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments. Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Abram MC; Renault D; Fattal E; Benech H; Deverre JR; Poncy JL Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474 [TBL] [Abstract][Full Text] [Related]
17. Toward an optimal DTPA therapy for decorporation of actinides: time-dose relationships for plutonium in the dog. I. Guilmette RA; Moretti ES; Lindenbaum A Radiat Res; 1979 Jun; 78(3):415-28. PubMed ID: 221958 [No Abstract] [Full Text] [Related]
18. [The applicability of the concept of morpho-physiologic metabolic factors to the modification of the distribution of 239Pu deposited in the respiratory organs]. Shvydko NS; Ivanova NP; Rushonik SI Radiobiologiia; 1990; 30(5):665-70. PubMed ID: 2251355 [TBL] [Abstract][Full Text] [Related]
19. [Distribution and excretion of plutonium-239 from the body of rats under exposure to penthacine and macro quantities of iron with penthacine]. Rushonik SI; Shvydko NS; Popov DK; Vorozhtsova LN Radiobiologiia; 1978; 18(5):719-23. PubMed ID: 715193 [No Abstract] [Full Text] [Related]
20. Salicylic acid failed to increase the efficacy of Ca-DTPA in the decorporation of plutonium and americium. Jones CW; Lloyd RD; Mays CW Radiat Res; 1980 Oct; 84(1):149-51. PubMed ID: 7454978 [No Abstract] [Full Text] [Related] [Next] [New Search]